MAPT and tauopathy: While iPSC-neurons remain relatively immature and do not express the full complement of tau isoforms (Sposito et al., 2015; Sato et al., 2018), we are able to capture molecular signatures that change during disease course in mouse models of tauopathy and patient brains.